Medicine & Life Sciences
Korea
100%
Registries
92%
Stents
85%
Myocardial Infarction
75%
Percutaneous Coronary Intervention
75%
Heart Failure
64%
Drug-Eluting Stents
59%
Multicenter Studies
51%
Fibrosis
49%
Type 2 Diabetes Mellitus
44%
Liver
44%
Portal Hypertension
43%
ST Elevation Myocardial Infarction
41%
Safety
39%
Confidence Intervals
38%
Mortality
38%
Therapeutics
38%
Liver Cirrhosis
35%
Venous Pressure
31%
zotarolimus
30%
Hemorrhage
29%
Sirolimus
28%
Mesenchymal Stem Cells
28%
Metabolic Syndrome
27%
Republic of Korea
26%
Diabetic Nephropathies
26%
Colonoscopy
26%
Serum
26%
Blood Pressure
25%
Odds Ratio
25%
Everolimus
24%
Colorectal Neoplasms
22%
Prospective Studies
21%
Brain Natriuretic Peptide
21%
Amlodipine
21%
Guidelines
20%
Incidence
19%
Chronic Hepatitis B
19%
Insulin Resistance
19%
Stomach
19%
Placebos
18%
Paclitaxel
18%
Propensity Score
18%
Human Influenza
17%
Kidney
17%
Polyps
17%
Liver Diseases
17%
Thrombosis
17%
Population
17%
Acute Coronary Syndrome
17%
Clopidogrel
16%
Randomized Controlled Trials
16%
Diabetes Mellitus
16%
Glucose
16%
Radial Artery
16%
Hypertension
16%
Neoplasms
16%
Podocytes
15%
Adiponectin
15%
Adenoma
15%
Cohort Studies
14%
Asthma
14%
Metformin
14%
Hepatocellular Carcinoma
13%
Non-alcoholic Fatty Liver Disease
13%
Obesity
13%
Inbred OLETF Rats
13%
Stroke Volume
13%
Aspirin
13%
Nutrition Surveys
13%
Angiotensin Receptor Antagonists
13%
Stomach Neoplasms
13%
fimasartan
12%
Alcoholic Liver Cirrhosis
11%
Non-ST Elevated Myocardial Infarction
11%
urushiol
11%
Multivariate Analysis
11%
Bacteremia
11%
Ultrasonography
11%
Essential Hypertension
11%
Sitagliptin Phosphate
11%
C-Reactive Protein
10%
Losartan
10%
End Stage Liver Disease
10%
Elasticity Imaging Techniques
10%
4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one
10%
Insulin
10%
Rhus
10%
Systolic Heart Failure
10%
Infections
10%
Coronary Angiography
10%
Hepatitis
10%
Survival
10%
Portal Pressure
10%
Fasting
10%
Chronic Disease
9%
Meta-Analysis
9%
High Fat Diet
9%
Blood Platelets
9%
Atrial Fibrillation
9%